Analyst Price Targets — TFX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 8, 2026 8:27 pm | Vik Chopra | BMO Capital | $159.00 | $130.35 | TheFly | Teleflex initiated with an Outperform at BMO Capital |
| June 8, 2026 8:00 am | Jason Bednar | Piper Sandler | $160.00 | $129.84 | StreetInsider | Piper Sandler Assumes Coverage and Upgrades Teleflex (TFX) to Overweight |
| May 8, 2026 1:15 pm | Jayson Bedford | Raymond James | $150.00 | $131.91 | TheFly | Teleflex price target raised to $150 from $128 at Raymond James |
| May 8, 2026 11:20 am | — | Mizuho Securities | $140.00 | $131.68 | TheFly | Teleflex price target raised to $140 from $135 at Mizuho |
| May 8, 2026 9:29 am | Shagun Singh | RBC Capital | $155.00 | $131.68 | TheFly | Teleflex upgraded to Outperform from Sector Perform at RBC Capital |
| March 27, 2026 9:11 am | — | Raymond James | $128.00 | $116.22 | TheFly | Teleflex upgraded to Outperform from Market Perform at Raymond James |
| February 26, 2026 7:30 pm | Mike Matson | Needham | $147.00 | $119.02 | StreetInsider | Teleflex (TFX) PT Raised to $147 at Needham |
| January 29, 2026 11:12 am | Remainco EPS | Wells Fargo | $116.00 | $105.33 | TheFly | Teleflex price target lowered to $116 from $139 at Wells Fargo |
| January 27, 2026 11:03 am | Mike Matson | Needham | $138.00 | $104.20 | TheFly | Teleflex upgraded to Buy from Hold at Needham |
| December 18, 2025 2:16 pm | — | Truist Financial | $135.00 | $123.77 | TheFly | Teleflex price target raised to $135 from $120 at Truist |
Latest News for TFX
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2025 Global Impact Report. The report outlines recent accomplishments and future plans to support the Company's Corporate Social Responsibility (CSR) program. The report aligns with the Global Reporting Initiative (GRI), the Sustainability Accounting Standards Board…
Investors need to pay close attention to TFX stock based on the movements in the options market lately.
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the beginning of enrollment in the BIOMAG™‑III Study (NCT07258290), a landmark global study evaluating the Freesolve™ Resorbable Magnesium Scaffold (RMS). Dr. Itsik Ben-Dor, MedStar Health in Washington, D.C., is the first implanter in the United States (U.S.) in the IDE trial of…
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up data from the First-in-Human BIOMAG™-I Clinical Study (NCT04157153)* presented at the EuroPCR conference in Paris, France by Prof. Jan Torzewski (Klinikverbund Allgäu, Germany). Conducted exclusively across European centers and enrolling 116 patients, the study…
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its private offering of $500.0 million aggregate principal amount of 5.875% senior notes due 2032 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on June 15, 2026, subject to customary closing conditions. The Notes will be guaranteed by each of Teleflex's existing and…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.